A new study by Tal-Brosh Nissimov and colleagues sheds light on the treatment outcomes of severely compromised patients grappling with persistent COVID-19. It discusses potential treatment strategies for this vilunerable population. #COVID19#persistentcovid#immumocompromised
Go #BehindTheStudy with Drs. Lennard YW Lee, Yuxin Ying and Jola Bytyci from @UniofOxford as they elaborate on a recent editorial they published in Oncoscience: “Exiting the pandemic together: achieving global immunity and equity”
Read, watch or listen ⬇️ https://t.co/ggHJPBs1nP
I'm incredibly grateful to work with amazing experts at @GICHcoalition . This week, I got to publish about this. 👇 Do have a read if you're interested- https://t.co/EPWz50gaOz. More experts will bring their viewpoints over the next few weeks. They're amazing heros.
Each year, pandemic ignored while the sun shines, yet waves crash ashore, 💀& #LongCovid 💔
Each year, we scramble to shore up vax, tests, NPIs... 😉😷
Flu, RSV always = #NHS pressure, now + SARS2😬
Perhaps next time the sun shines, we might fix the roof?
https://t.co/VcCQV7EFkl
Check out our NEW Blog Post! 🧬🧫
Boosting Protection: An Expert’s Perspective on Vaccination Boosters for Immunocompromised Individuals 🌎
https://t.co/lVy4R7irvL
@drlennardlee@cleverwebber
"I keep hearing about variants. Should I be concerned?"
@CDCDirector answers in this video ⬇️
Here's everything else you need to know about #COVID19: https://t.co/Ie7Kqshz2p